Jane Street’s Cognition Therapeutics CGTX Stock Holding History

Jane Street’s Portfolio CGTX Stock Details CGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-370,140	Closed	-$281K	–	11688
2026 Q1	$281K	Sell	370,140 -244,121	-40%	-$284K	﹤0.01%	9368
2025 Q4	$829K	Sell	614,261 -311,889	-34%	-$506K	﹤0.01%	6537
2025 Q3	$1.25M	Buy	926,150 +912,936	+6,909%	+$1.24M	﹤0.01%	5846
2025 Q2	$4.09K	Buy	+13,214	New	+$4.46K	﹤0.01%	9444
2025 Q1	–	Sell	-10,040	Closed	-$7.04K	–	9537
2024 Q4	$7.04K	Sell	10,040 -12,690	-56%	-$6.27K	﹤0.01%	9205
2024 Q3	$10.7K	Buy	+22,730	New	+$23.4K	﹤0.01%	9348

Other funds holding CGTX

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HCM

Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Jane Street's CGTX Position: Q2 2026 in Review

Jane Street sold out of Cognition Therapeutics (CGTX) in Q2 2026, closing a stake of 370,140 shares — an estimated $281K sold.

Jane Street first reported a position in CGTX in Q3 2024 and held it in 6 quarters. The position peaked at $1.25M in Q3 2025. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

Jane Street reported no remaining Cognition Therapeutics position as of Q2 2026 after selling out during the quarter.
Jane Street sold 370,140 Cognition Therapeutics shares in Q2 2026, an estimated $281K.
Jane Street first reported a position in Cognition Therapeutics in Q3 2024 and held it in 6 quarters.
Jane Street's Cognition Therapeutics position peaked at $1.25M in Q3 2025.
66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.